Oui, un statut socio-économique plus bas peut être associé à un risque accru d'infection.
Statut socio-économiqueTrichomonas vaginalis
#5
Les femmes ayant des partenaires multiples sont-elles à risque ?
Oui, les femmes ayant plusieurs partenaires sexuels sont à risque accru d'infection.
Partenaires multiplesInfections à protozoaires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Trichomonas vaginalis : Questions médicales les plus fréquentes",
"headline": "Trichomonas vaginalis : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Trichomonas vaginalis : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-26",
"dateModified": "2026-08-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Trichomonas vaginalis"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Trichomonas",
"url": "https://questionsmedicales.fr/mesh/D014244",
"about": {
"@type": "MedicalCondition",
"name": "Trichomonas",
"code": {
"@type": "MedicalCode",
"code": "D014244",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B01.630.800.808"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Trichomonas vaginalis",
"alternateName": "Trichomonas vaginalis",
"code": {
"@type": "MedicalCode",
"code": "D014246",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jae-Sook Ryu",
"url": "https://questionsmedicales.fr/author/Jae-Sook%20Ryu",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 04763, Korea."
}
},
{
"@type": "Person",
"name": "Marlene Benchimol",
"url": "https://questionsmedicales.fr/author/Marlene%20Benchimol",
"affiliation": {
"@type": "Organization",
"name": "Universidade do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil. Electronic address: marlenebenchimol@gmail.com."
}
},
{
"@type": "Person",
"name": "Jan Tachezy",
"url": "https://questionsmedicales.fr/author/Jan%20Tachezy",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic."
}
},
{
"@type": "Person",
"name": "Wanderley de Souza",
"url": "https://questionsmedicales.fr/author/Wanderley%20de%20Souza",
"affiliation": {
"@type": "Organization",
"name": "Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil."
}
},
{
"@type": "Person",
"name": "Abhijith Makki",
"url": "https://questionsmedicales.fr/author/Abhijith%20Makki",
"affiliation": {
"@type": "Organization",
"name": "Department of Parasitology, Faculty of Science, Charles University, BIOCEV, Vestec, Czech Republic."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Stimulation of microvesicle secretion in Trichomonas vaginalis.",
"datePublished": "2024-02-21",
"url": "https://questionsmedicales.fr/article/38395187",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.exppara.2024.108722"
}
},
{
"@type": "ScholarlyArticle",
"name": "Phenolic chalcones as agents against Trichomonas vaginalis.",
"datePublished": "2023-09-28",
"url": "https://questionsmedicales.fr/article/37839143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bioorg.2023.106888"
}
},
{
"@type": "ScholarlyArticle",
"name": "A hybrid TIM complex mediates protein import into hydrogenosomes of Trichomonas vaginalis.",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38825681",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12915-024-01928-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trichomonas vaginalis: comparison of primers for implementation as an in-house PCR in rural Vellore, South India.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39333912",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12879-024-09619-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Patterns of antibiotic resistance of Mycoplasma hominis endosymbiont of Trichomonas vaginalis and the influence of bacterial intracellular location on drug susceptibility.",
"datePublished": "2023-10-08",
"url": "https://questionsmedicales.fr/article/37816433",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jgar.2023.09.021"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Eucaryotes",
"item": "https://questionsmedicales.fr/mesh/D056890"
},
{
"@type": "ListItem",
"position": 3,
"name": "Parabasalidea",
"item": "https://questionsmedicales.fr/mesh/D056900"
},
{
"@type": "ListItem",
"position": 4,
"name": "Trichomonadida",
"item": "https://questionsmedicales.fr/mesh/D016834"
},
{
"@type": "ListItem",
"position": 5,
"name": "Trichomonas",
"item": "https://questionsmedicales.fr/mesh/D014244"
},
{
"@type": "ListItem",
"position": 6,
"name": "Trichomonas vaginalis",
"item": "https://questionsmedicales.fr/mesh/D014246"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Trichomonas vaginalis - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Trichomonas vaginalis",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Trichomonas vaginalis",
"description": "Comment diagnostiquer une infection à Trichomonas vaginalis ?\nQuels tests sont utilisés pour le diagnostic ?\nLes tests sanguins sont-ils utiles pour le diagnostic ?\nPeut-on diagnostiquer l'infection par auto-examen ?\nLes symptômes aident-ils au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Trichomonas vaginalis",
"description": "Quels sont les symptômes courants de l'infection ?\nL'infection peut-elle être asymptomatique ?\nLes hommes peuvent-ils avoir des symptômes ?\nComment se manifestent les pertes vaginales ?\nY a-t-il des symptômes associés à d'autres infections ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Trichomonas vaginalis",
"description": "Comment prévenir l'infection à Trichomonas vaginalis ?\nLes tests réguliers sont-ils recommandés ?\nL'hygiène personnelle aide-t-elle à prévenir l'infection ?\nLes femmes enceintes doivent-elles se faire tester ?\nLes douches vaginales sont-elles recommandées ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Trichomonas vaginalis",
"description": "Quel est le traitement standard pour l'infection ?\nLe traitement est-il le même pour les hommes et les femmes ?\nLes partenaires doivent-ils être traités aussi ?\nY a-t-il des effets secondaires au traitement ?\nLe traitement est-il efficace ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Trichomonas vaginalis",
"description": "Quelles complications peuvent survenir si non traitée ?\nL'infection peut-elle affecter la fertilité ?\nY a-t-il un risque accru de VIH ?\nLes complications sont-elles plus graves chez les femmes ?\nLes hommes peuvent-ils avoir des complications ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Trichomonas vaginalis",
"description": "Quels sont les principaux facteurs de risque ?\nL'âge influence-t-il le risque d'infection ?\nLes antécédents d'infections sexuellement transmissibles augmentent-ils le risque ?\nLe statut socio-économique joue-t-il un rôle ?\nLes femmes ayant des partenaires multiples sont-elles à risque ?",
"url": "https://questionsmedicales.fr/mesh/D014246#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection à Trichomonas vaginalis ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par un examen microscopique des sécrétions vaginales ou urinaires."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de culture, PCR ou des tests rapides peuvent être utilisés pour confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Les tests sanguins sont-ils utiles pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les tests sanguins ne sont pas utilisés pour diagnostiquer Trichomonas vaginalis."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'infection par auto-examen ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, un examen médical est nécessaire pour un diagnostic précis de l'infection."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent orienter le diagnostic, mais un test est nécessaire pour confirmation."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de l'infection ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des démangeaisons, des pertes vaginales anormales et des douleurs lors des rapports."
}
},
{
"@type": "Question",
"name": "L'infection peut-elle être asymptomatique ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, de nombreuses personnes infectées par Trichomonas vaginalis ne présentent pas de symptômes."
}
},
{
"@type": "Question",
"name": "Les hommes peuvent-ils avoir des symptômes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les hommes peuvent avoir des symptômes comme des douleurs lors de la miction ou des écoulements."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les pertes vaginales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les pertes peuvent être mousseuses, de couleur jaunâtre ou verdâtre, avec une odeur désagréable."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à d'autres infections ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être similaires à ceux d'autres infections sexuellement transmissibles."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection à Trichomonas vaginalis ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de préservatifs lors des rapports sexuels peut réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les tests réguliers sont-ils recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests réguliers pour les infections sexuellement transmissibles sont conseillés."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle aide-t-elle à prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une bonne hygiène personnelle peut aider, mais ne remplace pas l'utilisation de préservatifs."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles se faire tester ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes doivent être testées pour Trichomonas vaginalis pour éviter des complications."
}
},
{
"@type": "Question",
"name": "Les douches vaginales sont-elles recommandées ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les douches vaginales ne sont pas recommandées et peuvent perturber la flore vaginale."
}
},
{
"@type": "Question",
"name": "Quel est le traitement standard pour l'infection ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard est l'administration de métronidazole ou de tinidazole par voie orale."
}
},
{
"@type": "Question",
"name": "Le traitement est-il le même pour les hommes et les femmes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est généralement le même pour les hommes et les femmes infectés."
}
},
{
"@type": "Question",
"name": "Les partenaires doivent-ils être traités aussi ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est recommandé que les partenaires sexuels soient également traités pour éviter la réinfection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires au traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure des nausées, des maux de tête et des réactions allergiques."
}
},
{
"@type": "Question",
"name": "Le traitement est-il efficace ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le traitement est généralement très efficace, avec un taux de guérison élevé."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir si non traitée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, l'infection peut entraîner des complications comme des infections pelviennes."
}
},
{
"@type": "Question",
"name": "L'infection peut-elle affecter la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une infection non traitée peut augmenter le risque de problèmes de fertilité chez les femmes."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de VIH ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes infectées par Trichomonas vaginalis peuvent avoir un risque accru de contracter le VIH."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles plus graves chez les femmes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes peuvent éprouver des complications plus graves, notamment des douleurs pelviennes."
}
},
{
"@type": "Question",
"name": "Les hommes peuvent-ils avoir des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, bien que moins fréquentes, les hommes peuvent également développer des complications comme l'urétrite."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent des rapports sexuels non protégés et un nombre élevé de partenaires sexuels."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes, en particulier les femmes, sont plus à risque d'infection."
}
},
{
"@type": "Question",
"name": "Les antécédents d'infections sexuellement transmissibles augmentent-ils le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents d'autres infections sexuellement transmissibles augmente le risque."
}
},
{
"@type": "Question",
"name": "Le statut socio-économique joue-t-il un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un statut socio-économique plus bas peut être associé à un risque accru d'infection."
}
},
{
"@type": "Question",
"name": "Les femmes ayant des partenaires multiples sont-elles à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes ayant plusieurs partenaires sexuels sont à risque accru d'infection."
}
}
]
}
]
}
Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 04763, Korea.
Department of Biomedical Science, Hanyang University Graduate School of Biomedical Science and Engineering, Hanyang University College of Medicine, Seoul 04763, Korea.
Universidade do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil. Electronic address: marlenebenchimol@gmail.com.
Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil; CMABio da Escola Superior de Saúde, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil.
Universidade do Grande Rio, Duque de Caxias, Brazil; Laboratório de Ultraestrutura Celular Hertha Meyer, Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Centro de Ciências da Saúde, Bloco G, Rio de Janeiro, Brazil; Instituto Nacional de Ciência e Tecnologia and Centro Nacional de Biologia Estrutural e Bioimagem, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
Department of Biomedical Sciences, College of Medicine, Chang Gung University, Guishan District, Taoyuan City, Taiwan; Genomic Medicine Core Laboratory, Chang Gung Memorial Hospital, Linkou, Taiwan. Electronic address: pjhuang@gap.cgu.edu.tw.
Department of Parasitology, College of Medicine, Chang Gung University, Guishan District, Taoyuan City, Taiwan; Molecular Infectious Disease Research Center, Chang Gung Memorial Hospital, Linkou, Taiwan. Electronic address: petang@mail.cgu.edu.tw.
Department of Environmental Biology and Medical Parasitology, Hanyang University College of Medicine, Seoul 04763, Korea.
Department of Biomedical Science, Hanyang University Graduate School of Biomedical Science and Engineering, Hanyang University College of Medicine, Seoul 04763, Korea.
Trichomonas vaginalis is an extracellular flagellate protozoan and the etiological agent of human trichomoniasis, a sexually transmitted infection (STI) with a high incidence. Several reports have sho...
Trichomonas vaginalis, a flagellated and anaerobic protozoan, is a causative agent of trichomoniasis. This disease is among the world's most common non-viral sexually transmitted infection. A single c...
Hydrogenosomes are a specific type of mitochondria that have adapted for life under anaerobiosis. Limited availability of oxygen has resulted in the loss of the membrane-associated respiratory chain, ...
We report unprecedented modification of TIM in hydrogenosomes of the human parasite Trichomonas vaginalis (TvTIM). We show that the import of the presequence-containing protein into the hydrogenosomal...
The hybrid TvTIM in hydrogenosomes represents an original structural solution that evolved for protein import when Δψ is negligible and remarkable example of evolutionary adaptation to an anaerobic li...
Trichomonas vaginalis (TV) accounts for the highest burden of curable, non-viral sexually transmitted infections worldwide. Prevalence in India ranges from 0.4 to 27.4% in women and 0.0-5.6% in men. I...
Six-hundred adult, sexually active women attending the Obstetrics-Gynaecology rural out-patient clinic the Rural Unit for Health and Social Affairs (RUHSA) from July 2020 - February 2021 were enrolled...
Nine specimens (9/600, 1.5%) were positive for TV. There was a 100% correlation between Biomed InPouch TV...
Current hospital-based prevalence of TV in rural Vellore was 1.5%. Repetitive DNA target TVK 3/7 was more sensitive than AP65 and BTUB 9/2 primers....
Mycoplasma hominis, an opportunistic pathogen of the human lower urogenital tract, can survive and replicate within the protozoan Trichomonas vaginalis, establishing an endosymbiotic relationship. The...
We evaluated antibiotic resistance patterns in a group of M. hominis isolated from T. vaginalis clinical specimens as well as in M. hominis isolated from patients without trichomoniasis. Using an expe...
The incidence rate of M. hominis strains resistant to C14 and C15 macrolide antibiotics was higher in intracellular strains associated with T. vaginalis compared with extracellular bacteria isolated f...
The intracellular localization of bacteria within trichomonad cells may affect antibiotic susceptibility....
This study was undertaken to determine the prevalence of Bacterial Vaginosis (BV), Trichomonas Vaginalis (TV) co-infection, and the antibacterial sensitivity profile of bacterial isolates....
The study was a cross-sectional study of 232 pregnant women on a routine antenatal visit between April 2019 and Sept. 2020, at Amukoko clinic in Lagos, Nigeria. The gynaecologist conducted the clinica...
The mean age of the clients was 28.11 ± 7.08 years of age. The majority (88%) were aged 15-35 years. Only 81 (34.9%) had microbial organisms isolated or seen from their specimens and 19 (8.2%) of such...
There is a relatively low prevalence of BV and flagellate co-infection in the community studied....
We recommend screening of antenatal women with underlying symptoms for BV and flagellates co-infection to avoid its progression to vaginitis....
Trichomoniasis is caused by a sexually transmitted flagellate protozoan parasite Trichomonas vaginalis. T. vaginalis-derived secretory products (TvSP) contain lipid mediators such as leukotriene B4 (L...
We previously reported that leukotriene B4 (LTB4) contained in Trichomonas vaginalis-derived secretory products (TvSP) play an essential role in interleukin-8 (IL-8) production in human mast cell line...
In 2018, the World Health Organization commenced a multi-country validation study of the Cepheid GeneXpert for a range of molecular-based point-of-care (POC) tests in primary care settings. One study ...
Study participants completed a pre-test questionnaire which included demographics, clinical information and general questions on POC testing (POCT). Two vaginal swab samples (either self-collected or ...
One thousand three hundred and eighty-three women were enrolled: 58.6% from South Africa, 29.2% from Morocco, 6.2% from Guatemala, and 6.0% from Australia. 1296 samples for CT/NG and 1380 samples for ...
This multi-country evaluation is the first of its kind world-wide. Positive likelihood ratios, as well as specificity estimates, indicate the GeneXpert POC test results for CT, NG and TV were clinical...
Ethics approval to conduct the ProSPeRo study was granted by the WHO Ethics Review Committee, as well as local ethics committees from all participating countries....
Sexually transmitted infections caused by Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV) remain significant global health problems. The World Health Organization...
A comprehensive training program for the study was developed. Quality control (QC) and external quality assessment (EQA) samples were provided by an accredited quality assurance provider. QC testing w...
For QC testing, concordance with the expected results for CT and NG was > 99% and rates of unsuccessful tests were < 4%. For TV testing, concordance was similar (97%), but rates of unsuccessful tests ...
The high level of concordance for QC and EQA testing confirm that the trained operators at the POC clinical sites were competent to conduct POC testing and that the training and quality systems implem...
Ethics approval to conduct the ProSPeRo study was granted by the WHO Ethics Review Committee....